EyeBio

📍 London, United Kingdom🗓 Founded 2021👥 42 employees💰 Last funded Jun 2021
Biotechnology Research🌐 eyebiotech.com
Website LinkedIn
EyeBio is a privately held ophthalmology biotechnology company dedicated to developing and delivering a new generation of therapies to protect, restore, and improve vision in patients with sight-threatening eye diseases.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2021
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in EyeBio?
EyeBio has 1 investors on record on gritt.io, including 1 early-stage backers.
When did EyeBio last raise funding?
The most recent investment in EyeBio recorded on gritt.io was in June 2021.
When was EyeBio founded?
EyeBio was founded in 2021.
What industry is EyeBio in?
EyeBio operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is EyeBio based?
EyeBio is headquartered in London, United Kingdom.